Journal of Clinical Oncology (JCO) Podcast

Late Relapse in Hodgkin Lymphoma Persisting Even at 20 Years: Implications for Therapeutic Intensity and Disease Biology

2017/2/28

This podcast discusses the JCO article, "Late Relapse of classical Hodgkin Lymphoma: An Analysis of

Intensification of Consolidation Therapy for Acute Myeloid Leukemia by the Addition of Clofarabine to Cytarabine Improves Relapse-Free Survival

2017/2/21

By Kenneth Bradstock This podcast describes a clinical trial of clofarabine in consolidation therapy

Characterizing the Patterns of Clonal Evolution in Ibrutinib-Treated CLL: A Roadmap for Continued Progress

2017/2/13

Dr. Wiestner highlights characteristics of ibrutinib resistant CLL as reported by Woyach and colleag

Prevalence of Germline Mutations in Individuals With Colorectal Cancer as Determined Using a Multi-Gene Panel Test

2017/1/30

Summary and discussion of JCO paper by Yurgelun at al. using a 25-gene panel to demonstrate a nearly

Financial Barriers to Cancer Care for Patients Obtaining Insurance on the Federal Exchange

2017/1/11

By Stacie B. Dusetzina Considering the role of network coverage on access to accredited cancer insti

Mindfulness-Based Interventions in Oncology: Not for Everyone?

2016/11/21

By Linda E. Carlson This podcast discusses the target study in the context of other research on mind

The Impact of Oral Targeted Therapies on the Cost of Care for Patients With Chronic Lymphocytic Leukemia

2016/11/21

By Christopher R. Flowers Modeling studies like the one presented by Qiushi Chen and colleagues can

Watching Nivolumab’s Balancing Act: How Immune Activation May Affect Both Safety and Efficacy in Patients With Advanced Melanoma

2016/11/14

This podcast provides commentary on a large dataset describing the expected frequency, severity and

Getting to the Heart of the Matter: Biomarkers for the Assessment of Trastuzumab-Induced Cardiac Dysfunction

2016/10/26

By Deepa Rangachari This podcast focuses on the use of trastuzumab in adjuvant therapy for early sta

Listen to Your Patients

2016/10/3

If you are an oncologist and think that it isn’t part of your job to listen to your patients talk ab

Impact of Organizational Characteristics and Process of Care on Hospital Mortality and Resource Use in Cancer Patients Admitted to Intensive Care Units

2016/9/13

Health-Related Quality of Life: Increasingly Important in the Era of Effective, Modern Myeloma Therapy

2016/9/6

Chemotherapy Induced Peripheral Neuropathy: A Novel Method of Exploration

2016/8/14

This podcast highlights the innovative methodology employed in this study to determine risk factors

Changes in the Epidemiology of AIDS-Related Kaposi’s Sarcoma and Lymphomas: How This Informs the Clinician

2016/8/8

This podcast will assist readers in understanding the clinical implications of the paper by Yanik an

Implicit Racial Bias Affects Key Aspects of Physician Communication

2016/7/14

Implicit bias affects oncologists and their patients - a few steps can help

Nivolumab Monotherapy is Safe and Active in Hematologic Malignancies

2016/7/14

This podcast is a discussion of a clinical trial by Lesokhin et al which evaluated nivolumab monothe

Minimizing Frailty in Cancer Survivors: A Meaningful Goal for All Ages

2016/7/13

This podcast discusses the prevalence of and risk factors associated with a phenotype of accelerated

1q Gain, a Prognostic Biomarker in Nephroblastoma, and What’s Next?

2016/7/11

This podcast comments on two independent pediatric studies on both sides of the Atlantic showing the

Therapy Impacts Long-Term Survival for Patients in Germany With Heritable Retinoblastoma

2016/7/5

While ten-year overall survival has increased for German patients with heritable retinoblastoma, tre

Dexamethasone and High-Dose Methotrexate in High-Risk B Cell Acute Lymphoblastic Leukemia—Where Should We Go From Here?

2016/7/1

The Children's Oncology Group study led by Larsen et al. showed that children and young adult patien

Episodes